The Competition Bureau has released updated Intellectual Property Enforcement Guidelines. The guidelines are directed to the Bureau’s approach to investigating anti-competitive activities relating to intellectual property including settlements, particularly in PM(NOC) proceedings, price-fixing, patent pooling, product switching, patent assertion entities and standard essential patents.

Continue reading IPEGs

Gene Patents

For those following Children’s Hospital of Eastern Ontario’s challenge to the validity of certain gene patents in the Federal Court (T-2249-14 – see earlier post), CHEO has announced a settlement:  “the patent holder Transgenomic has agreed to provide CHEO and all other Canadian public sector hospitals and laboratories the right to test Canadians for Long QT syndrome on a not-for-profit basis”.

Continue reading Gene Patents